Cargando…

Epidemiology Features and Effectiveness of Vaccination and Non-Pharmaceutical Interventions of Delta and Lambda SARS-CoV-2 Variants

Detalles Bibliográficos
Autores principales:	Bai, Wenqing, Gu, Yue, Liu, Haoliang, Zhou, Lei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8598544/ https://www.ncbi.nlm.nih.gov/pubmed/34804631 http://dx.doi.org/10.46234/ccdcw2021.216

Ejemplares similares

The Lambda variant of SARS-CoV-2 has a better chance than the Delta variant to escape vaccines
por: Liu, Haolin, et al.
Publicado: (2021)

Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study
por: Sonabend, Raphael, et al.
Publicado: (2021)

The impact of spike mutated variants of SARS-CoV2 [Alpha, Beta, Gamma, Delta, and Lambda] on the efficacy of subunit recombinant vaccines
por: Mohammadi, Mehrdad, et al.
Publicado: (2021)

Modeling the dynamics of COVID-19 in the presence of Delta and Omicron variants with vaccination and non-pharmaceutical interventions
por: Saha, Shikha, et al.
Publicado: (2023)

Clinical characteristics and severity of beta and delta variants of SARS-CoV-2 and the effect of vaccine on delta variants
por: Peng, Yahui, et al.
Publicado: (2022)

Appropriate relaxation of non-pharmaceutical interventions minimizes the risk of a resurgence in SARS-CoV-2 infections in spite of the Delta variant
por: Koslow, Wadim, et al.
Publicado: (2022)

Generation time of the alpha and delta SARS-CoV-2 variants: an epidemiological analysis
por: Hart, William S, et al.
Publicado: (2022)

Modeling vaccination rollouts, SARS-CoV-2 variants and the requirement for non-pharmaceutical interventions in Italy
por: Giordano, Giulia, et al.
Publicado: (2021)

Mitigating the SARS-CoV-2 Delta disease burden in Australia by non-pharmaceutical interventions and vaccinating children: a modelling analysis
por: Milne, George J., et al.
Publicado: (2022)

Influence of the Delta Variant and Vaccination on the SARS-CoV-2 Viral Load
por: Migueres, Marion, et al.
Publicado: (2022)

SARS-CoV-2 Delta variant isolates from vaccinated individuals
por: Brinkac, Lauren, et al.
Publicado: (2022)

Epidemiological characteristics of Omicron and Delta SARS-CoV-2 variant infection in Santiago, Chile
por: Mella-Torres, Andrea, et al.
Publicado: (2022)

Severity, Pathogenicity and Transmissibility of Delta and Lambda Variants of SARS-CoV-2, Toxicity of Spike Protein and Possibilities for Future Prevention of COVID-19
por: Moghaddar, Mehrnoosh, et al.
Publicado: (2021)

Cost-Effective Method to Perform SARS-CoV-2 Variant Surveillance: Detection of Alpha, Gamma, Lambda, Delta, Epsilon, and Zeta in Argentina
por: Torres, Carolina, et al.
Publicado: (2021)

Immunologic features of asymptomatic postvaccination infections with the Delta variant of SARS‐CoV‐2 in adults
por: Duan, Rui, et al.
Publicado: (2022)

SARS-CoV-2 delta variant: a persistent threat to the effectiveness of vaccines
por: Thiruvengadam, Ramachandran, et al.
Publicado: (2022)

Effect of vaccination on household transmission of SARS-CoV-2 Delta variant of concern
por: Lyngse, Frederik Plesner, et al.
Publicado: (2022)

Vaccine Effect on Household Transmission of Omicron and Delta SARS-CoV-2 Variants
por: Kim, Yong Chan, et al.
Publicado: (2022)

Regional clustering and waves patterns due to COVID-19 by the index virus and the lambda/gamma, and delta/omicron SARS-CoV-2 variants in Peru
por: Toyama, Melissa, et al.
Publicado: (2022)

Regional clustering and waves patterns due to COVID-19 by the index virus and the lambda/gamma, and delta/omicron SARS-CoV-2 variants in Peru
por: Toyama, Melissa, et al.
Publicado: (2023)

Contact tracing period and epidemiological characteristics of an outbreak of the SARS-CoV-2 Delta variant in Guangzhou
por: Ma, Xiaowei, et al.
Publicado: (2022)

Epidemiologic Analysis of Delta Variant SARS-CoV-2 in a Cohort of Lung Transplant Recipients
por: Shaver, C.M., et al.
Publicado: (2022)

Delta Variant of SARS-CoV-2 Replacement in Brazil: A National Epidemiologic Surveillance Program
por: Silva, Joice P., et al.
Publicado: (2022)

Clinical and laboratory profiles of the SARS-CoV-2 Delta variant compared with pre-Delta variants()
por: Bhakta, Shivang, et al.
Publicado: (2022)

SARS-CoV-2 Lambda (C.37): An emerging variant of concern?
por: Darvishi, Mohammad, et al.
Publicado: (2021)

Shortening Epitopes to Survive: The Case of SARS-CoV-2 Lambda Variant
por: Pascarella, Stefano, et al.
Publicado: (2021)

Increased resistance of SARS-CoV-2 Lambda variant to antibody neutralization
por: Guo, Huimin, et al.
Publicado: (2022)

Evolutionary analysis of the Delta and Delta Plus variants of the SARS-CoV-2 viruses
por: Kannan, Saathvik R., et al.
Publicado: (2021)

Is the SARS CoV-2 Omicron Variant Deadlier and More Transmissible Than Delta Variant?
por: Duong, Bao V., et al.
Publicado: (2022)

BNT162b2-elicited neutralization of Delta plus, Lambda, Mu, B.1.1.519, and Theta SARS-CoV-2 variants
por: Liu, Jianying, et al.
Publicado: (2022)

What is the vaccine effect on reducing transmission in the context of the SARS-CoV-2 delta variant?
por: Wilder-Smith, Annelies
Publicado: (2022)

Modeling the Transmission of the SARS-CoV-2 Delta Variant in a Partially Vaccinated Population
por: Avila-Ponce de León, Ugo, et al.
Publicado: (2022)

A systematic review of Vaccine Breakthrough Infections by SARS-CoV-2 Delta Variant
por: Zhang, Mengxin, et al.
Publicado: (2022)

Breakthrough infections with the SARS-CoV-2 Delta variant: vaccinations halved transmission risk
por: Hsu, L., et al.
Publicado: (2022)

SARS-CoV-2 Vaccine Breakthrough by Omicron and Delta Variants, New York, USA
por: Keyel, Alexander C., et al.
Publicado: (2022)

Effect of booster vaccination against Delta and Omicron SARS-CoV-2 variants in Iceland
por: Norddahl, Gudmundur L., et al.
Publicado: (2022)

SARS-CoV-2 Vaccine Breakthrough Infections of Omicron and Delta Variants in Healthcare Workers
por: Regenhardt, Elisa, et al.
Publicado: (2023)

Epidemiological analysis of SARS-COV-2 B.1.617.2 (delta variant) transmission in an educational institute
por: Vishnu Prasad, S., et al.
Publicado: (2022)

Transmission Dynamics and Epidemiological Characteristics of the SARS-CoV-2 Delta Variant ― Hunan Province, China, 2021
por: Luo, Kaiwei, et al.
Publicado: (2023)

Reduced sensitivity of the SARS-CoV-2 Lambda variant to monoclonal antibodies and neutralizing antibodies induced by infection and vaccination
por: Wang, Meiyu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_307o0rfagjp8p1aiqgt5j3ffhl